Cargando…

DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway

The treatment of osteosarcoma (OS) is still mainly surgery combined with systematic chemotherapy, and gene therapy is expected to improve the survival rate of patients. This study aimed to explore the effect of DEP domain 1 protein (DEPDC1) and kinesin super-family protein 4A (KIF4A) in OS and under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Mingming, Zhang, Hang, Gao, Shichang, Huang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972622/ https://www.ncbi.nlm.nih.gov/pubmed/36849972 http://dx.doi.org/10.1186/s13018-023-03572-4

Ejemplares similares

DEPDC1 as a crucial factor in the progression of human osteosarcoma
por: Shen, Lin, et al.
Publicado: (2022)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

Knockdown of DEPDC1B inhibits the development of glioblastoma
por: Chen, Xu, et al.
Publicado: (2020)

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
por: Yang, Xianliang, et al.
Publicado: (2021)

SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway
por: Wu, Zhiqiang, et al.
Publicado: (2020)

DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23)
por: Shen, Enhua, et al.
Publicado: (2022)

DEPDC1B promotes development of cholangiocarcinoma through enhancing the stability of CDK1 and regulating malignant phenotypes
por: Zhang, Zhenhai, et al.
Publicado: (2022)

KIF21B Expression in Osteosarcoma and Its Regulatory Effect on Osteosarcoma Cell Proliferation and Apoptosis Through the PI3K/AKT Pathway
por: Ni, Songjia, et al.
Publicado: (2021)

DEPDC7 inhibits cell proliferation, migration and invasion in hepatoma cells
por: Liao, Zhijun, et al.
Publicado: (2017)

TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway
por: Jin, Shan, et al.
Publicado: (2018)

Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway
por: Park, Sang-Soo, et al.
Publicado: (2023)

FOXO3a-modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β-catenin signaling pathway
por: Geng, Geng, et al.
Publicado: (2022)

Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
por: Liu, Jie, et al.
Publicado: (2017)

MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3
por: Tan, Yuelong, et al.
Publicado: (2020)

DEPDC1 up‐regulates RAS expression to inhibit autophagy in lung adenocarcinoma cells
por: Wang, Wei, et al.
Publicado: (2020)

Getting Sucker Punched by Depdc5 Really Hurts
por: Weston, Matthew
Publicado: (2020)

The Role of Hippo Pathway in Cancer Stem Cell Biology
por: Park, Jae Hyung, et al.
Publicado: (2018)

RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway
por: Zhan, Fangbiao, et al.
Publicado: (2021)

MicroRNA‐188 inhibits biological activity of lung cancer stem cells through targeting MDK and mediating the Hippo pathway
por: Yang, Xiaolin, et al.
Publicado: (2020)

KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway
por: Xiong, Man, et al.
Publicado: (2019)

Epileptic spasms are a feature of DEPDC5 mTORopathy
por: Carvill, Gemma L., et al.
Publicado: (2015)

Partial deletion of DEPDC5 in a child with focal epilepsy
por: Bonaglia, Maria Clara, et al.
Publicado: (2016)

DEPDC1B collaborates with GABRD to regulate ESCC progression
por: Yuan, Yunfeng, et al.
Publicado: (2022)

LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma
por: Guo, Chengyong, et al.
Publicado: (2019)

KIF18B promotes tumor progression in osteosarcoma by activating β-catenin
por: Gao, Tian, et al.
Publicado: (2020)

Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
por: Bouvier, Corinne, et al.
Publicado: (2016)

Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway
por: Xu, Lin, et al.
Publicado: (2021)

Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer
por: Ji, Zhiyu, et al.
Publicado: (2021)

DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1
por: Lai, Chin-Hui, et al.
Publicado: (2020)

ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A
por: Wang, Yuchen, et al.
Publicado: (2021)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway
por: Li, Yang, et al.
Publicado: (2022)

Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
por: Yang, Qu, et al.
Publicado: (2021)

DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma
por: Feng, Xuefei, et al.
Publicado: (2017)

Cardiac Investigations in Sudden Unexpected Death in DEPDC5 ‐Related Epilepsy
por: Bacq, Alexandre, et al.
Publicado: (2021)

Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells
por: Kassambara, Alboukadel, et al.
Publicado: (2013)

Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway
por: Huang, Guangzhao, et al.
Publicado: (2023)

Artemisia argyi Essential Oil Inhibits Hepatocellular Carcinoma Metastasis via Suppression of DEPDC1 Dependent Wnt/β-Catenin Signaling Pathway
por: Li, Yanli, et al.
Publicado: (2021)

Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
por: Sekido, Yoshitaka
Publicado: (2018)

KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors
por: Terribas, Ernest, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_do7rko63ie5508taje3iekg0gj